Literature DB >> 12743735

Application of real-time polymerase chain reaction technology to detect prostatic bacteria in patients with chronic prostatitis/chronic pelvic pain syndrome.

Satoshi Takahashi1, Donald E Riley, John N Krieger.   

Abstract

To investigate the potential association between prostate infection and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), we used molecular approaches described in previous reports. These methods employed standard polymerase chain (PCR) reaction assays to provide a qualitative evaluation of prostatic bacterial species. Here, we report on the detection of prostatic bacteria using a real-time PCR. Template DNAs were examined from prostatic tissue samples from patients with CP/CPPS. Two PCR primer sets were used: one that amplifies a portion of all known bacterial ribosomal DNAs (16S rDNAs) and one that is specific for Escherichia coli as opposed to related, E. coli-like bacteria. The 16S rDNA real-time PCR assay detected bacterial DNAs in eight (26%) of 31 samples from patients with CP/CPPS, including three samples (10%) that were also positive by the E. coli real-time PCR assay. These E. coli positives were quantified at approximately 10(3) cfu/ml of tissue digested. Quantification, speed and specificity make real-time PCR a promising approach for the quantitative detection and identification of prostatic bacteria from CP/CPPS patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12743735     DOI: 10.1007/s00345-003-0326-3

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  20 in total

Review 1.  Chronic prostatitis-an infectious disease?

Authors:  K G Naber; W Weidner
Journal:  J Antimicrob Chemother       Date:  2000-08       Impact factor: 5.790

2.  Rapid detection of herpes simplex virus DNA in genital ulcers by real-time PCR using SYBR green I dye as the detection signal.

Authors:  Carmen Aldea; Carmen P Alvarez; Lola Folgueira; Rafael Delgado; Joaquín R Otero
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Use of real-time PCR and the LightCycler system for the rapid detection of Pneumocystis carinii in respiratory specimens.

Authors:  S Palladino; I Kay; R Fonte; J Flexman
Journal:  Diagn Microbiol Infect Dis       Date:  2001-04       Impact factor: 2.803

4.  A real-time PCR assay for the detection of Neisseria gonorrhoeae by LightCycler.

Authors:  David M Whiley; Genevera M LeCornec; Ian M Mackay; David J Siebert; Theo P Sloots
Journal:  Diagn Microbiol Infect Dis       Date:  2002-02       Impact factor: 2.803

5.  Detection of Cryptococcus neoformans DNA in tissue samples by nested and real-time PCR assays.

Authors:  Ralf Bialek; Michael Weiss; Kubrom Bekure-Nemariam; Laura K Najvar; Maria B Alberdi; John R Graybill; Udo Reischl
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

6.  Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction.

Authors:  W W Hochreiter; J L Duncan; A J Schaeffer
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

7.  Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis.

Authors:  J N Krieger; D E Riley; M C Roberts; R E Berger
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

8.  Use of a LightCycler gyrA mutation assay for identification of ciprofloxacin-resistant Campylobacter coli.

Authors:  Alessandra Carattoli; Anna Dionisi; Ida Luzzi
Journal:  FEMS Microbiol Lett       Date:  2002-08-27       Impact factor: 2.742

9.  Detection of Bacillus anthracis DNA by LightCycler PCR.

Authors:  Constance A Bell; James R Uhl; Ted L Hadfield; John C David; Richard F Meyer; Thomas F Smith; Franklin R Cockerill
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  Comprehensive evaluation and treatment of 75 men referred to chronic prostatitis clinic.

Authors:  J N Krieger; K J Egan
Journal:  Urology       Date:  1991-07       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.